Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

ISMPP EU

- PMLiVE

PMGroup Worldwide Ltd and The Datateam Media Group welcome Samedan Ltd

Samedan joins PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Group’s healthcare division

- PMLiVE

Celebrating the Communiqué Awards 2021

Recognising excellence in medical affairs and healthcare communications at the first face-to-face Communiqué Awards since the outbreak of the COVID-19 pandemic

- PMLiVE

New data advances AstraZeneca’s “revolution in oncology”

In a busy few weeks for AstraZeneca, the company will present data on 14 approved and potential drugs in lung and breast cancer

- PMLiVE

FDA experts to evaluate Pfizer-BioNTech COVID-19 booster

As Moderna announces it has submitted COVID-19 vaccine booster data, the FDA advisory committee of outside experts will convene in two weeks’ time

- PMLiVE

FDA nod for Janssen schizophrenia treatment Invega Hafyera

The phase 3 study results showed that 92% of patients were relapse-free after 12 months

Making Wearable Technology Scalable and Adoptable

Ilaria Varoli, EVP of Myant Inc., explores Textile Computing™ for remote monitoring, health assessments, pediatric and maternal care, temperature regulation, monitoring of athlete performance, and much more.

Impetus Digital

Lucid Group celebrates a double win at Communiqué 2021

Lucid scooped a double win at this year’s Communiqué awards, the first face-to-face industry event since the start of the pandemic – making it an extra-special occasion for everyone attending....

Lucid Group Communications Limited

Courageous Conversation ep.12: Not Going Back: How COVID Has Changed Clinical Trials

Natalie Yeadon, CEO & Co-Founder at Impetus Digital, provides insight into how COVID has changed clinical trials.

Impetus Digital

Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on how to inspire creativity with virtual working groups.

Impetus Digital

- PMLiVE

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

The approval for the Novartis drug by the NHS gatekeeper could save 30,000 lives over 10 years

- PMLiVE

Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention

The MOVe-AHEAD trial will test whether the drug prevents infection in those living in the same household as someone with confirmed COVID-19

- PMLiVE

McCann Health, Dovetail, Evoke and Oxford PharmaGenesis among big winners at Communiqué Awards

See the full list of the results from the Awards held at London’s Grosvenor House Hotel

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links